Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DANAPAROID: 170 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
170
Total FAERS Reports
67 (39.4%)
Deaths Reported
75
Hospitalizations
170
As Primary/Secondary Suspect
21
Life-Threatening
1
Disabilities
Dec 24, 1996
FDA Approved
Discontinued
Status

Active Ingredient: DANAPAROID SODIUM · FDA Application: 020430 ·

First Report: 201103 · Latest Report: 20240101

What Are the Most Common DANAPAROID Side Effects?

#1 Most Reported
Heparin-induced thrombocytopenia
27 reports (15.9%)
#2 Most Reported
Shock haemorrhagic
14 reports (8.2%)
#3 Most Reported
Acute kidney injury
14 reports (8.2%)

All DANAPAROID Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Heparin-induced thrombocytopenia 27 15.9% 8 19
Acute kidney injury 14 8.2% 11 3
Shock haemorrhagic 14 8.2% 11 2
Haematoma 12 7.1% 9 4
Thrombocytopenia 12 7.1% 3 5
Off label use 11 6.5% 2 8
Deep vein thrombosis 10 5.9% 2 7
International normalised ratio increased 10 5.9% 7 3
Anaemia 9 5.3% 0 8
Haemorrhage 9 5.3% 5 0
Maternal exposure during pregnancy 9 5.3% 0 0
Rectal haemorrhage 9 5.3% 1 8
Cerebral haemorrhage 8 4.7% 8 2
Stevens-johnson syndrome 8 4.7% 8 0
Condition aggravated 7 4.1% 1 6
Drug ineffective 7 4.1% 4 2
Therapeutic product cross-reactivity 7 4.1% 1 5
Exposure during pregnancy 5 2.9% 0 0
Foetal exposure during pregnancy 5 2.9% 0 0
Haemorrhagic anaemia 5 2.9% 1 4

Who Reports DANAPAROID Side Effects? Age & Gender Data

Gender: 63.1% female, 36.9% male. Average age: 63.4 years. Most reports from: FR. View detailed demographics →

Is DANAPAROID Getting Safer? Reports by Year

YearReportsDeathsHosp.
2011 3 1 2
2012 3 3 0
2013 3 1 3
2014 14 6 8
2015 14 2 12
2016 5 2 4
2017 6 2 3
2018 18 10 9
2019 7 1 6
2020 3 0 3
2021 7 1 6
2022 4 2 1
2023 13 8 5
2024 4 0 0

View full timeline →

What Is DANAPAROID Used For?

IndicationReports
Product used for unknown indication 50
Heparin-induced thrombocytopenia 34
Thrombosis prophylaxis 22
Anticoagulant therapy 18
Pulmonary embolism 15
Thrombocytopenia 5

DANAPAROID vs Alternatives: Which Is Safer?

DANAPAROID vs DANAZOL DANAPAROID vs DANICOPAN DANAPAROID vs DANTROLENE DANAPAROID vs DAPAGLIFLOZIN DANAPAROID vs DAPAGLIFLOZIN PROPANEDIOL DANAPAROID vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN DANAPAROID vs DAPRODUSTAT DANAPAROID vs DAPSONE DANAPAROID vs DAPTOMYCIN DANAPAROID vs DARATUMUMAB

Official FDA Label for DANAPAROID

Official prescribing information from the FDA-approved drug label.